Pelthos Therapeutics Inc. (PTHS) has 3 open-market insider trades by 3 insiders since 2025. Over the last six months insiders net bought $960K. The most active filer is Todd C. Davis, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Todd C. Davis | Dir | — | 1 | $1000K | 2026-06-11 |
| Ezra M. Friedberg | Dir | — | 1 | $280K | 2026-07-02 |
| Knuettel Francis II | CFO | — | 1 | $40K | 2026-05-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Peter Greenleaf | Director | Sell | $17K | 2026-10-02 |
| Peter Greenleaf | Director | Sell | $12K | 2026-10-02 |
| Peter Greenleaf | Director | Sell | $17K | 2026-10-02 |
| Peter Greenleaf | Director | Sell | $21K | 2026-07-02 |
| Matthew Pauls | Director | Sell | $21K | 2026-07-02 |
| Ezra M. Friedberg | Director | Sell | $15K | 2026-07-02 |
Companies that share insiders with PTHS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Ezra M. Friedberg | Director | Sell | $8K | 2026-06-15 |
| Todd C. Davis | Director | Buy | $1000K | 2026-06-11 |
| Knuettel Francis II | CFO | Sell | $40K | 2026-05-22 |
| Matthew Pauls | Director | Sell | $16K | 2026-04-02 |
| Richard Malamut | Director | Sell | $12K | 2026-04-02 |
| Peter Greenleaf | Director | Sell | $17K | 2026-04-02 |
| Ezra M. Friedberg | Director | Sell | $12K | 2026-04-02 |
| Ezra M. Friedberg | Director | Sell | $280K | 2025-11-25 |